Biotech and Pharma Stocks Decline Amid Rotation Into Energy Sector Indian Equities Surge as Vinay Rajani Flags LT Finance and Sandur Manganese as Potential NearTerm Picks 3M India Declares 506 Per Share Dividend Final and Special Payout Announced for Shareholders Momentus Stock Surges Nearly 300 in Two Days as Space Company Secures Additional Financing Standard Chartered Plans Significant Job Cuts in Corporate Functions to Boost Profitability Silver Price Outlook Key Drivers and Market Expectations for the Next Decade Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss Meets Optimism in Gene Therapy Pipeline CLOV Q1 2026 Earnings EPS Surges Past Estimates Driving Stock Higher PALI Q1 2026 Earnings EPS Misses Estimates as Palisade Bio Advances Pipeline Efforts Twin Vee PowerCats Co VEEE Q2 2025 Earnings Loss Per Share Deepens Amid Market Headwinds Stock Gains on Sentiment VUZI Q1 2026 Earnings EPS Beat and Narrowed Loss Boost Investor Sentiment GDYN Q1 2026 Earnings EPS Beats Estimates on Improved Operational Efficiency Cohen Steers ClosedEnd Opportunity Fund FOF Edges Higher Key Levels in Focus Cantor Equity Partners III CAEP Holds Steady at 150 as Support and Resistance Levels Tighten Foremost Clean Energy FMST Dips Nearly 3 Key Support Level in Focus AbbVie ABBV Shows Modest Gain as Biotech Sector Stabilizes Invesco Mortgage Capital IVR Edges Lower Amid Broader Mortgage REIT Pressure Plus500 Reports 11 Revenue Growth in Latest Quarter Reaffirms FullYear Expectations VLTO Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Performance Aurora Innovation Warrants AUROW Slide 109 as Resistance Caps Recovery at 042 NEUP Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency COMPASS Pathways Q1 2026 Earnings Narrower Loss and Positive Stock Response Amid Clinical Progress GXO Logistics Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain Turn Therapeutics Inc TTRX Q1 2026 Earnings Narrow EPS Miss Overshadowed by Operational Progress Enbridge ENB Q1 2026 Earnings Solid Earnings Beat Driven by Operational Strength CNTX Q1 2026 Earnings Context Therapeutics Beats EPS Estimates with NarrowerThanExpected Loss SANA Q1 2026 Earnings Narrower Loss Per Share Surprises on Operational Progress